Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
so they make a pointless comment about finances and funding for no reason whatsoever. I've never known a company on AIM do that. They always announce the placing and then it's done they never scare the market to crash the stock. Then low and behold months after there's an offer just at the right time the VWA is low killing all the PI's who were in for the long hall. I think a complaint to the FCA is warranted.
Over 42500000 shares.
We need 26% to stop it
I’m just pleased I bought more last week so cut my losses a little but still massive loss.
Shafted
It’s was only a hearing based on motions filed. Some were thrown out some were stayed. Both sides were trying to get each other expert witness removed probably didn’t work. No big deal I inagine you’d need a very good argument to remove an expert witness.
Apparently anyone can be on the Jury and it's a known problem that they don't really understand what's going on especially in electronic, biotec and software cases. I suppose it's all going to come down to how good the legal team is at translating the necessary information so they understand what has actually been infringed. A good thing on our part I think is the way Maxwell has behaved, they're on their 3rd legal team why the change. They came up with a story that they'd been making these parts for years before the patent was granted but they had no evidence of this apart from an old part that was found in someones garage (or something like that) if it looks suspect I'm sure any reasonable thinking person will think the same thing, they're willing to try anything to get out of this. I hope so anyway!
In proposing jury instructions, the parties have an opportunity to persuade the trial court to present their view of the law or theory of the case. In this respect, crafting and proposing instructions requires a deep under- standing of the governing law, as much so as argu- ing a summary judgment or post-trial motion.
Hopefully we’ll get an update on the 7th regarding resubmission and possible funding
Sales of our recently launched ALKINDI SPRINKLE® remain strong, with 293% year-over-year revenue growth, and feedback from the patient and physician communities continues to be overwhelmingly positive.
Continued growth in ALKINDI SPRINKLE®. ALKINDI SPRINKLE sales grew 293% over the second quarter of 2021 and 34% over the first quarter of 2022, demonstrating a strong desire for the low-dose treatment options that ALKINDI SPRINKLE offers.
Cap x didn't withdraw their counter claim the withdrew there opening brief. We asked in July for a summary judgement on Maxwells claims, Maxwell asked for a partial dismissal of this and the judge granted it. This means the opening brief is now irrelevant so they need to change it. Thats how I understand it anyway.